Travera Revenue and Competitors
Estimated Revenue & Valuation
- Travera's estimated annual revenue is currently $3.3M per year.
- Travera's estimated revenue per employee is $155,000
Employee Data
- Travera has 21 Employees.
- Travera grew their employee count by 62% last year.
Travera's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and Chief Technology Officer | Reveal Email/Phone |
2 | Co-founder and VP Clinical Development | Reveal Email/Phone |
3 | VP Business Development | Reveal Email/Phone |
4 | Senior Research Technician | Reveal Email/Phone |
5 | Research Technician | Reveal Email/Phone |
6 | Research Engineer | Reveal Email/Phone |
7 | Research Technician | Reveal Email/Phone |
Travera Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Travera?
Travera was founded in 2017 to commercialize a breakthrough measurement technology and biomarker developed in the Manalis Laboratory in the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT). The company’s initial test is based on this technology; a new measurement tool called the Suspended Microchannel Resonator (SMR) that makes exquisitely precise measurements of the effects of cancer drugs on cancer cells.
keywords:N/AN/A
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
62%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.6M | 21 | -19% | N/A |
#2 | $2.1M | 21 | -5% | $28.4M |
#3 | $2.1M | 21 | -12% | N/A |
#4 | $7.5M | 21 | 5% | N/A |
#5 | $2.4M | 21 | -5% | N/A |